AstraZeneca Investors Rejoice After COPD Drug Performs in Phase IV Study Post author:Sam Post published:December 3, 2017 Post category:BioPharma Tudorza, also marketed as Eklira and Bretaris, is available in more than 50 countries. Source: BioSpace You Might Also Like MabVax Therapeutics Presents Two Posters At The AACR Annual Meeting On A Novel Radioimmunotherapy Treatment For Pancreatic Cancer April 4, 2017 Swedish Orphan AB – Elocta Approved In The Kingdom Of Saudi Arabia For The Treatment Of Haemophilia A May 17, 2017 <b>Luye Life Sciences</b> Expands Global Reach As New Boston R&D Center Opens July 16, 2017
MabVax Therapeutics Presents Two Posters At The AACR Annual Meeting On A Novel Radioimmunotherapy Treatment For Pancreatic Cancer April 4, 2017
Swedish Orphan AB – Elocta Approved In The Kingdom Of Saudi Arabia For The Treatment Of Haemophilia A May 17, 2017
